# Liposomal Bupivacaine Interscalene Nerve Block in Shoulder Arthroplasty

> **NCT03663283** · PHASE4 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 104 (actual)

## Conditions studied

- Arthropathy Shoulder

## Interventions

- **DRUG:** Liposomal Bupivacaine
- **DRUG:** Bupivacaine Hydrochloride

## Key facts

- **NCT ID:** NCT03663283
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-29
- **Primary completion:** 2020-02-14
- **Final completion:** 2020-02-14
- **Target enrollment:** 104 (ACTUAL)
- **Last updated:** 2021-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03663283

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03663283, "Liposomal Bupivacaine Interscalene Nerve Block in Shoulder Arthroplasty". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03663283. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*